Fig. 5

Association between positive TFAP2D immunostaining and androgen receptor (AR) status in all cancers, ERG negative and ERG positive cancers
Association between positive TFAP2D immunostaining and androgen receptor (AR) status in all cancers, ERG negative and ERG positive cancers